Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 542 shares (to pay taxes)
  5. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 643 shares (to pay taxes)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 625 shares (to pay taxes)
  8. 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)
  9. 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)
  10. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 576 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 577 shares (to pay taxes)

Page 5 of 29 · 574 filings